Evidence map›Paper›PMID 42265826›Full record

ReviewMolecular genetics & genomic medicine2026

Phenotypic Refinement of ESAM-Related Tight-Junctionopathy: Novel Genetic and Ocular Findings and Literature Review.

Mauro Lecca, Chiara Bosetti, Federico Ruoli, Liviana Fontanel, Marco Mazza, Enza Maria Valente, Roberta Battini, Edoardo Errichiello

Abstract readCase ReportsReview
In one paragraph

Review in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mauro LeccaDepartment of Molecular Medicine, Unit of Medical Genetics, University of Pavia, Pavia, Italy.
Chiara BosettiDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
Federico RuoliPediatric Ophthalmology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Liviana FontanelPediatric Ophthalmology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Marco MazzaPediatric Ophthalmology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Enza Maria ValenteDepartment of Molecular Medicine, Unit of Medical Genetics, University of Pavia, Pavia, Italy.ORCID https://orcid.org/0000-0002-0600-6820
Roberta BattiniDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
Edoardo ErrichielloDepartment of Molecular Medicine, Unit of Medical Genetics, University of Pavia, Pavia, Italy.ORCID https://orcid.org/0000-0001-6346-1988

Funding

Italian Health Ministry RC 2022-2024
6 · The paper itself

Abstract

backgroundEndothelial cell-selective adhesion molecule (ESAM) is a tight junction protein essential for blood-brain barrier integrity and angiogenesis. Bi-allelic loss-of-function variants in ESAM cause NEDIHSS ("Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity"), a neurodevelopmental/neurovascular disorder with antenatal/neonatal onset, characterized by global developmental delay/intellectual disability (GDD/ID), epilepsy, spasticity, ventriculomegaly, and intracranial hemorrhages. Ocular involvement, particularly retinal vascular anomalies, has been variably reported.

methodsA multidisciplinary team of pediatric neurologists, ophthalmologists, and clinical geneticists evaluated the proband through clinical assessment, neuro/ocular imaging, and whole-exome sequencing.

resultsWe describe a 3-year-old male from consanguineous Albanian parents carrying a novel homozygous splice-site ESAM variant (c.70+1G>T). He presented with GDD, seizures, and brain imaging abnormalities consistent with NEDIHSS. Remarkably, bilateral optic nerve hypoplasia, esotropia, retinal detachment, absent electroretinogram response, and structural eye anomalies, including left eyeball hypoplasia and iris displacement, were observed. Review of our and previous cases indicates that 45% (10/22) of NEDIHSS individuals present ocular manifestations, mainly retinal vascular defects, reinforcing the emerging role of ESAM in retinal endothelial integrity.

conclusionsThis case broadens the mutational and clinical spectrum of ESAM-related disease, underscores the need for detailed ocular evaluations in NEDIHSS, and supports inclusion of retinal anomalies within its core phenotype.

Indexed as

Cell Adhesion MoleculesPhenotypeChild, PreschoolHumansMaleMutationPedigreeTight JunctionsCell Adhesion Moleculeselectroretinogram (ERG)ESAMfamilial exudative vitreoretinopathy (FEVR)retinatight junction (TJ)whole exome sequencing (WES)

Identifiers

PMID42265826
PMCPMC13249801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.